The Effect of Serum Phosphate Level on Fibroblast Growth Factor 23 in Maintenance Hemodialysis Patients

杨涛,蔡美顺,王玉柱,任树风
DOI: https://doi.org/10.3969/j.issn.1009-587x.2009.09.008
2009-01-01
Abstract:Objective:Serum phosphate level is one of important regulators of fibroblast growth factor(FGF-23)in health adults.We detected the serum phosphate level in maintenance hemodialysis(MHD)patients to observe whether serum phosphate still is a efffect factor on fibroblast growth factor 23.Methods:Sixty seven MHD patients and twenty eight people(control group)whose renal functions were normal were enrolled in this study.According the serum phosphate level,MHD patients were divided into three groups:lower serum phosphate group,standard serum phosphate group and higher serum phosphate group.Alkaline phosphatase,calcium,phosphate and parathyroid hormone in their serum were determined also.The level of 1,25(OH)2D3 and FGF-23 in serum were detected by the method of ELISA.Results:The serum level of FGF-23 in MHD group was much higher than control(P0.01),but there were no significant differences in the FGF-23 among lower serum phosphate group,standard serum phosphate group and higher serum phosphate group(P0.05),and the serum parathormone level in higher serum phosphate group was higher than other(P0.05).We didn't find a positive correlation between serum FGF-23 and phosphate in MHD patients(r=0.018,P0.05).Multiple linear regression analysis revealed that the level of 1,25(OH)2D3 was the influencing factor of FGF-23 in MHD patients(β=0.521,P0.01).Conclusion:The serum level of FGF-23 in MHD patients is extremely higher.The serum phosphate level isn't a influencing factor of FGF-23 in MHD patients.
What problem does this paper attempt to address?